Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary Book PDF, ePub eBook

Join our eBook service for unlimited books & audiobooks. Get a free 7 day subscription! ↓↓↓↓↓


Book Descriptions:

Despite the extensive body of evidence that informs regulatory decisions on pharmaceutical products, significant uncertainties persist, including the underlying variability in human biology, factors associated with the chemistry of a drug, and limitations in the research and clinical trial process itself that might limit the generalizability of results. As a result, regulatory reviewers are consistently required to draw conclusions about a drug's safety and efficacy from imperfect data. Efforts are underway within the drug development community to enhance the evaluation and communication of the benefits and risks associated with pharmaceutical products, aimed at increasing the predictability, transparency, and efficiency of pharmaceutical regulatory decision making. Effectively communicating regulatory decisions necessarily includes explanation of the impact of uncertainty on decision making.

On February 12 and May 12, 2014, the Institute of Medicine's Forum on Drug Discovery, Development, and Translation held public workshops to advance the development of more systematic and structured approaches to characterize and communicate the sources of uncertainty in the assessment of benefits and risks, and to consider their implications for pharmaceutical regulatory decisions. Workshop presentations and discussions on February 12 were convened to explore the science of identifying and characterizing uncertainty in scientific evidence and approaches to translate uncertainties into decisions that reflect the values of stakeholders. The May 12 workshop presentations and discussions explored tools and approaches to communicating about scientific uncertainties to a range of stakeholders in the drug development process. Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products summarizes the presentation and discussion of both events. This report explores potential analytical and communication approaches and identifies key considerations on their development, evaluation, and incorporation into pharmaceutical benefit- risk assessment throughout the entire drug development lifecycle.

Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary by Denise Caruso, Rebecca A. English, Anne B. Claiborne, Development, and Translation Forum on Drug Discovery, Board on Health Sciences Policy, Institute of Medicine

From reader reviews:

Melinda Anderson:

Have you spare time for a day? What do you do when you have more or little spare time? Yes, you can choose the suitable activity for spend your time. Any person spent their own spare time to take a stroll, shopping, or went to typically the Mall. How about open or even read a book eligible Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary? Maybe it is being best activity for you. You already know beside you can spend your time with your favorite's book, you can smarter than before. Do you agree with it is opinion or you have some other opinion?

Steven Allen:

What do you regarding book? It is not important along? Or just adding material if you want something to explain what your own problem? How about your extra time? Or are you busy man or woman? If you don't have spare time to try and do others business, it is gives you the sense of being bored faster. And you have time? What did you do? Everybody has many questions above. They must answer that question since just their can do this. It said that about book. Book is familiar on every person. Yes, it is right. Because start from on guardería until university need that Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary to read.

Pandora Rice:

Is it anyone who having spare time in that case spend it whole day by simply watching television programs or just lying on the bed? Do you need something totally new? This Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary can be the solution, oh how comes? A fresh book you know. You are so out of date, spending your spare time by reading in this fresh era is common not a nerd activity. So what these textbooks have than the others?

Lawrence Wilson:

Reserve is one of source of expertise. We can add our information from it. Not only for students but native or citizen need book to know the revise information of year to be able to year. As we know those books have many advantages. Beside most of us add our knowledge, also can bring us to around the world. Through the book Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary we can get more advantage. Don't that you be creative people? Being creative person must want to read a book. Just choose the best book that acceptable with your aim. Don't become doubt to change your life at this time book Characterizing and Communicating Uncertainty in the Assessment of Benefits and Risks of Pharmaceutical Products: Workshop Summary. You can more inviting than now.